drugset / Trial / NCT05673239
Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients
Phase 4
Completed
1008 enrolled
The First Affiliated Hospital of Zhejiang Chinese Medical University
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is intended to be a multicenter, prospective, non-randomized, controlled real-world study. Patients receiving L-carnitine injection were included in the experimental group and the control group according to whether they received L-carnitine injection. Patients receiving L-carnitine injection were included in the experimental group, and those receiving L-carnitine injection were included in the control group.To observe the effects of L-carnitine on cardiac function in hemodialysis patients.
Timeline
- Start
- 2023-01-15
- Primary completion
- 2023-06-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 10 mg/kg | — |
| Subject | L-carnitine | Other / unclassified | 20 mg/kg | — |
| Subject | L-carnitine | Other / unclassified | 1 g | — |
| Subject | L-carnitine | Other / unclassified | 2 g | — |
Indications
No indication recorded.